Reading a molecular weight distribution honestly: why gpc chromatography reports a distribution relative to a calibration rather than an absolute mass, what conventional calibration hides and what light scattering detection settles, how column set, solvent and temperature bound the range you can see, why gpc software choices about baselines and integration limits change the reported averages as much as the chemistry does, and what a method has to state before two laboratories can compare results

Size exclusion separation produces a curve, and every number quoted from that curve depends on choices someone made: the calibration standards, where the baseline was drawn, where the integration limits sat and which detector was believed. Two laboratories can run the same sample and report different averages while both being internally correct.

laboratory records, the clause behind a distribution report
211.194
the competence standard a testing laboratory is assessed against
17025
current good manufacturing practice for finished pharmaceuticals, 21 CFR
Part 211

The figures in this panel are regulation and standard identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply an instrument price index it has not measured.

Making the numbers comparable

  1. State the calibration basis every time. Conventional calibration reports mass relative to the standards used, and a polymer that differs in shape from those standards will be reported wrongly. Naming the standard set is not optional context; it is part of the result.
  2. Add light scattering where absolute mass matters. A scattering detector measures mass directly rather than by comparison, which removes the standard dependence. It requires knowing the refractive index increment for the sample and it repays the effort where the value must be defended.
  3. Choose the column set for the whole distribution. A column set resolves a range, and material outside that range is reported at the limits rather than accurately. Include the tails when choosing, because the tails are usually where the interesting behaviour is.
  4. Fix baseline and integration limits in the method. Where the operator places the baseline and the start and end of integration moves the reported averages substantially. Define them in the method rather than leaving them to judgement per run.
  5. Control temperature and solvent as method parameters. Retention depends on both, and a solvent change alters the separation and sometimes the sample. Treat them as fixed method parameters with tolerances rather than as laboratory conditions.
  6. Run a check standard in every sequence. A well characterised sample run alongside the batch shows whether the system and the integration are behaving. It is the only routine evidence that today's numbers are comparable to last month's.

Relative numbers with absolute confidence

The most common misreading in this technique is treating a calibrated average as an absolute mass. It is a comparison to a set of standards, and the further the sample's behaviour is from those standards, the larger the discrepancy.

That is entirely workable for comparing batches of the same material, which is what most laboratories actually need. It stops working the moment the number is quoted as a property of the molecule.

Software is part of the method

Peak detection thresholds, baseline algorithms, slice by slice calculations and how the software handles the tails all affect the reported averages. Two packages on the same raw data will not agree unless configured to.

Record the software, its version and the processing method with the result, and keep the raw chromatogram. Without those a number cannot be reproduced even inside the same laboratory.

hic chromatography, and when hydrophobicity is the handle

hic chromatography separates on surface hydrophobicity: the sample is loaded at high salt so hydrophobic patches bind, then eluted as the salt falls. It is the mode to reach for when charge and size have already failed, which in practice means separating a protein from a variant of itself, an oxidised form or a differently folded one, and it is the standard way to profile antibody drug conjugates by drug load. It is gentler than reversed phase because there is no organic solvent, and it costs a buffer exchange before and often after the column.

hplc-sec, and the calibration behind a size

Size exclusion run on an HPLC is a relative method: the column separates by hydrodynamic volume and the elution time is converted to a size by a calibration curve of standards, so the answer is only as good as the standards' resemblance to the sample. That is why a protein aggregate figure and a polymer molecular weight are both quoted with the standard named. Mobile phase matters more than in other modes, because anything that makes the analyte interact with the packing breaks the assumption the calibration rests on, and a salt concentration that is too low does exactly that.

monolith chromatography, and the format's advantage

A monolith is a single continuous porous block rather than a bed of particles, with channels large enough that transport happens by convection instead of diffusion. For large molecules, plasmid DNA, viruses, very large proteins, that changes everything: capacity does not collapse at high flow, back pressure stays low, and a separation that takes an hour on beads takes minutes. The costs are lower capacity per millilitre for small molecules, where beads remain better, and a limited set of chemistries and sizes, so a monolith step is designed around what is available.

sec hplc, and the column volume it needs

Size exclusion has no binding step, so the whole separation happens in the column's own volume and the sample has to be a small fraction of it, typically a couple of per cent or less. That single fact sets the method: resolution comes from column length and bed quality rather than from a gradient, the flow rate has to be low enough for the molecules to sample the pores, and a big injection simply broadens everything. Running it on an HPLC adds reproducible flow and a detector, which is what turns an aggregate shoulder into a percentage.

An hplc column for oligonucleotides, and the two modes that work

An hplc column for oligonucleotides is either anion exchange, which separates by length and charge and tolerates a crude sample, or reversed phase with an ion pairing agent, which resolves closely related sequences and suits mass spectrometry. Pore size has to admit the oligonucleotide, and a column used with an ion pairing agent is effectively dedicated to that method afterwards.

An hplc to uplc method converter, and what it recalculates

An hplc to uplc method converter scales a method to smaller particles and a shorter column, holding linear velocity and gradient slope so the separation survives, and it predicts the far higher pressure the new configuration needs. Injection volume and detector time constant scale too, and a converted method that keeps the old detector settings loses the resolution the transfer was for.

An hplc column comparison chart, and how to read one

An hplc column comparison chart maps one maker's phases onto another's by hydrophobicity, silanol activity and shape selectivity, which is what makes a substitution rational rather than hopeful. Two columns close on a chart can still differ on a specific pair of peaks, so the chart narrows the candidates and the method's own critical pair decides. Batch to batch data belong beside it.

Common questions

Why do two laboratories report different molecular weights?
Different calibration standards, different integration limits or different column sets, usually all three. Harmonising the method, not the instrument, is what makes results comparable.
Is light scattering always better?
It gives absolute mass and removes standard dependence, at the cost of more method development and the need for accurate refractive index increment values. For routine comparative work conventional calibration is often adequate if the basis is stated.
How much does integration matter?
Considerably, particularly for the averages that weight the tails. Two analysts integrating the same chromatogram differently can report meaningfully different values, which is why the limits belong in the method.
What should a report contain?
The calibration basis and standards, the column set, solvent, temperature and flow, the detector configuration, the integration limits, and the check standard result for the sequence. Averages alone are not interpretable.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/gpc-chromatography/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices